华为云CEO周跃峰：以场景驱动创新，让医疗AI真正普惠

Core Viewpoint - Huawei emphasizes the transformative potential of AI in reshaping traditional medical service models, aiming to enhance the efficient utilization of scarce quality medical resources in China [1]. Group 1: Strategic Initiatives - Huawei Cloud has launched the "Industry AI Dream Factory" smart medical section and the RuiPath smart pathology integrated machine, marking a significant step in the practical application of medical AI [1][5]. - The company has served over 1,800 tertiary hospitals across China, building a solid understanding and practical experience in the healthcare sector [5]. Group 2: Technological Framework - The RuiPath smart pathology integrated machine utilizes a "cloud-edge-end" collaborative architecture, enabling advanced pathology capabilities from top hospitals to be accessible at the grassroots level, thus lowering the barriers for AI pathology technology adoption [5]. - Huawei's smart medical section integrates clinical experiences from top medical institutions with its expertise in ICT, cloud computing, and AI, creating an end-to-end medical AI support system covering "scenarios-models-platforms-communities" [6]. Group 3: Collaborative Ecosystem - The development of medical AI is presented as a collective effort requiring participation from various stakeholders, including medical institutions, tech companies, research units, and developers [7]. - Huawei aims to simplify medical AI innovation, ensuring that every hospital, doctor, and patient can benefit from these advancements [7].